Navigation Links
Shawn Cain Appointed New Chief Operating Officer Of LSNE
Date:12/4/2013

MANCHESTER, N.H., Dec. 4, 2013 /PRNewswire/ -- Lyophilization Services of New England (LSNE), a New Hampshire based contract manufacturing organization is pleased to announce that Shawn Cain has been named, Chief Operating Officer, a new position within the company.  Mr. Cain joined LSNE in 2012 as Vice President of Sterile Manufacturing.  In his new role, Cain will be leading operations, quality, regulatory, and will drive the overall strategic growth of LSNE.  Shawn will be responsible for overseeing day-to-day operations and ensuring companywide alignment with the corporate goals.  Mr. Cain will report to Matthew Halvorsen, President and Chief Executive Officer of LSNE.

"Shawn brings over 25 years of industry experience to the position and he has proven to be a trusted leader with a strong track record of manufacturing success.  I have tremendous confidence in his ability to lead the company with a focus on customer experience coupled with regulatory compliance.  This new appointment underlines LSNE's commitment to continuous improvement and risk management in an era of changing regulation," said Matthew Halvorsen.

Commenting on his recent promotion, Mr. Cain said, "LSNE has a strong foundation and I look forward to continuing the strong growth of the company. I am exciting to be working with such a talented and dedicated team." 

Mr. Cain's 28 year career includes extensive experience in the pharmaceutical, biotech and medical device industries.  Shawn has held key management positions within operations at Organogenesis, Inc, Formatech Inc., Arbios Systems, Inc. and Becton Dickinson.  Mr. Cain received his M.S. degree in Biological Sciences from the University of Massachusetts and a B.S. in Biological Sciences from Northeastern University. 

About LSNE Contract Manufacturing

LSNE Contract Manufacturing is a privately held company with three GMP facilities located in New England.   LSNE has been providing contract lyophilization services to the pharmaceutical, biotechnology and medical device industries since 1997, specializing in a wide range of services including cycle development, cGMP fill/finish, and lyophilization.  Through the thoughtful integration of three processing facilities, qualified staffing, and an extensive manufacturing history, LSNE is strategically positioned to provide uninterrupted manufacturing for clinical through commercial supply for medical device and pharmaceuticals to a multi-national market.

Media Contact
Christine Palus
Vice President of Sales & Marketing
(603) 668-5763
info@lyophilization.com
www.lyophilization.com


'/>"/>
SOURCE Lyophilization Services of New England
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Metamark Genetics Board of Directors Appoints Shawn M. Marcell President and Chief Executive Officer
2. Highmark executive Michael Fiaschetti Appointed to Board of Pennsylvania eHealth Partnership Authority
3. Regina E. Dugan Appointed to Board of Directors of Varian Medical Systems
4. Quest International Appointed As Authorized Reseller For Sony Electronics Medical Systems Division
5. Yvonne Vergurgt Appointed Sr. Director Business Development At Formex, LLC
6. John Ault Appointed Director of Business Development for MedTek Systems LLC
7. Medical Laser Expert Robert E. Grove, PhD Appointed To Ellman International Board of Directors
8. Former Pfizer/Wyeth Global Infectious Disease Pharmaceutical Executive, Lewis Barrett, Appointed Senior Vice President, Commercial Strategy of Synthetic Biologics, Inc.
9. Ulrich Michel Appointed Chief Financial Officer of Sirona Dental Systems, Inc.
10. Ron Jellison appointed Head of KMC Systems
11. Lilly Disappointed in Draft Medicare Coverage Decision for Beta-Amyloid Imaging Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
Breaking Medicine News(10 mins):